Published online Apr 14, 2024. doi: 10.3748/wjg.v30.i14.1934
Peer-review started: November 30, 2023
First decision: February 2, 2024
Revised: February 3, 2024
Accepted: March 25, 2024
Article in press: March 25, 2024
Published online: April 14, 2024
Processing time: 134 Days and 4.5 Hours
Olympus Corporation developed texture and color enhancement imaging (TXI) as a novel image-enhancing endoscopic technique. This topic highlights a series of hot-topic articles that investigated the efficacy of TXI for gastrointestinal disease identification in the clinical setting. A randomized controlled trial demonstrated improvements in the colorectal adenoma detection rate (ADR) and the mean number of adenomas per procedure (MAP) of TXI compared with those of white-light imaging (WLI) observation (58.7% vs 42.7%, adjusted relative risk 1.35, 95%CI: 1.17-1.56; 1.36 vs 0.89, adjusted incident risk ratio 1.48, 95%CI: 1.22-1.80, respectively). A cross-over study also showed that the colorectal MAP and ADR in TXI were higher than those in WLI (1.5 vs 1.0, adjusted odds ratio 1.4, 95%CI: 1.2-1.6; 58.2% vs 46.8%, 1.5, 1.0-2.3, respectively). A randomized controlled trial demonstrated non-inferiority of TXI to narrow-band imaging in the colorectal mean number of adenomas and sessile serrated lesions per procedure (0.29 vs 0.30, difference for non-inferiority -0.01, 95%CI: -0.10 to 0.08). A cohort study found that scoring for ulcerative colitis severity using TXI could predict relapse of ulcerative colitis. A cross-sectional study found that TXI improved the gastric cancer detection rate compared to WLI (0.71% vs 0.29%). A cross-sectional study revealed that the sensitivity and accuracy for active Helicobacter pylori gastritis in TXI were higher than those of WLI (69.2% vs 52.5% and 85.3% vs 78.7%, res
Core Tip: Olympus Corporation has developed texture and color enhancement imaging (TXI) as a novel image-enhancing endoscopy technique. This highlights a series of hot-topic articles investigating the usefulness of TXI for gastrointestinal disease diagnosis in clinical practice. TXI showed improvement compared with white-light imaging (WLI) and non-inferiority compared with narrow-band imaging in detecting colorectal neoplasia. TXI observation can predict the relapse of ulcerative colitis. TXI improved gastric cancer detection and diagnostic accuracy for active Helicobacter pylori gastritis compared to WLI. In conclusion, TXI can improve detection and qualitative diagnosis.